VIVO Cannabis Inc. (TSX: VIVO)
Health Care · Pharmaceuticals · CA
CA$—
— today · — 1Y
VIVO Cannabis Inc. (TSX: VIVO) operates in the Pharmaceuticals industry within the Health Care sector.
Tweenvest scores VIVO Cannabis Inc. across four factors: quality 33/100, growth 89/100. Its strongest factor is growth.
VIVO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $18.78M
- P/E
- —
- EPS
- -0.13
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- CA$—
- 52-week low
- CA$—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 155
- Next earnings
- —
About VIVO Cannabis Inc.
VIVO Cannabis Inc. cultivates and markets cannabis products, serving both the medical and adult-use sectors in Canada, Germany, and Australia. Its diverse product range features dried flower, pre-rolls, and cannabis oils, distributed under prominent brands such as Canna Farms, Beacon Medical, Fireside, and Lumina. Furthermore, the company extends its reach through the Harvest Medicine network of medical cannabis clinics and the HMED Connect telemedicine platform, an online portal for medical cannabis access. VIVO Cannabis also specializes in ethanol extraction, product formulation, and compliance with EU-GMP processes. The company's headquarters are located in Napanee, Canada.
- Listed since
- Jan 24, 2020
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.